Coverage
Filings
| Filing | Date |
|---|---|
| Genmab Revises Financial Guidance | 5 Nov 2009 |
| Genmab Achieves Milestone in Arzerra Collaboration | 27 Oct 2009 |
| GSK and Genmab Receive Accelerated Approval for Arzerra | 26 Oct 2009 |
| Articles of Association | 22 Oct 2009 |
| Major Shareholder Announcement | 13 Oct 2009 |
| Declaratory Judgment Action Filed by GSK | 8 Oct 2009 |
| Grant of Warrants to Employees in Genmab A/S | 8 Oct 2009 |
| Genmab to Attend Four September Investor Conferences |
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 2 Sept 2009 |
| Genmab Announces Positive Top-Line Results for Arzerra TM in Front Line NHL | 26 Aug 2009 |
| Interim Report for the 6 months ended June 30, 2009 | 18 Aug 2009 |
| Genmab Announces 2009 First Half Year Results | 18 Aug 2009 |
| GlaxoSmithKline and Genmab Announce Results from a Study of Arzerra in Rituximab Refractory Follicular NHL | 17 Aug 2009 |